Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in Scotland https://www.medrxiv.org/content/10.1101/2023.06.09.23291195
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in Scotland https://www.medrxiv.org/content/10.1101/2023.06.09.23291195